Volume 23 - Issue 12 - December 2015
News
01/22/2016
FDA has approved Allergan’s supplemental new drug application to update the label for dalbavancin (Dalvance) for injection. The expanded label will include a single dose administered as a 30-minute intravenous (IV) infusion of dalbavancin for...
FDA has approved Allergan’s supplemental new drug application to update the label for dalbavancin (Dalvance) for injection. The expanded label will include a single dose administered as a 30-minute intravenous (IV) infusion of dalbavancin for...
FDA has approved Allergan’s...
01/22/2016
The Dermatologist
NPF Endorsed Features
12/18/2015
New research finds the incidence of psoriatic arthritis (PsA) among patients with psoriasis is much greater than previously thought.
New research finds the incidence of psoriatic arthritis (PsA) among patients with psoriasis is much greater than previously thought.
New research finds the incidence...
12/18/2015
The Dermatologist
FDA Alerts
01/16/2016
The FDA recently approved secukinumab (Cosentyx) for 2 new indications for the treatment of adult patients with active ankylosing spondylitis (AS) and active psoriatic arthritis (PsA).
The FDA recently approved secukinumab (Cosentyx) for 2 new indications for the treatment of adult patients with active ankylosing spondylitis (AS) and active psoriatic arthritis (PsA).
The FDA recently approved...
01/16/2016
The Dermatologist
12/18/2015
In this excerpt from the recently published book, Practical Psoriasis Management, the author discusses the use of apremilast for moderate-to-severe psoriasis.
In this excerpt from the recently published book, Practical Psoriasis Management, the author discusses the use of apremilast for moderate-to-severe psoriasis.
In this excerpt from the...
12/18/2015
The Dermatologist
News
01/08/2016
A recent open label study,1 conducted between July and September 2012, examined microbial communities of patients with psoriasis vulgaris who were characterized prior and post a 3-week selenium-rich water balneotherapy treatment at the...
A recent open label study,1 conducted between July and September 2012, examined microbial communities of patients with psoriasis vulgaris who were characterized prior and post a 3-week selenium-rich water balneotherapy treatment at the...
A recent open label...
01/08/2016
The Dermatologist
NPF Endorsed Features
12/18/2015
Eileen Koutnik-Fotopoulos
This article reviews the current biologic therapies for the treatment of psoriasis and psoriatic arthritis, discusses the importance of patient and clinician education in the decision-making process and highlights drugs in the...
This article reviews the current biologic therapies for the treatment of psoriasis and psoriatic arthritis, discusses the importance of patient and clinician education in the decision-making process and highlights drugs in the...
This article reviews...
12/18/2015
The Dermatologist
News
01/06/2016
L’Oréal Group’s skincare brand, La Roche-Posay, revealed its My UV Patch, a novel stretchable skin sensor designed to monitor UV exposure and help consumers educate themselves about sun protection, at the Consumer Electronics Show today.
L’Oréal Group’s skincare brand, La Roche-Posay, revealed its My UV Patch, a novel stretchable skin sensor designed to monitor UV exposure and help consumers educate themselves about sun protection, at the Consumer Electronics Show today.
L’Oréal Group’s skincare brand,...
01/06/2016
The Dermatologist
12/16/2015
Posters from the Fall clinical conference look at patient experiences with psoriasis, as well as therapies for this common chronic skin disease.
Posters from the Fall clinical conference look at patient experiences with psoriasis, as well as therapies for this common chronic skin disease.
Posters from the Fall clinical...
12/16/2015
The Dermatologist
The Dermatopathologist
12/22/2015
Christine R. Moussa, MD; Najiyah Kazi, MD; Richard Bernet, MD; Cynthia M. Magro, MD
A 23-year-old man presented with aclassic presentation of generalized eruptive histiocytosis.
A 23-year-old man presented with aclassic presentation of generalized eruptive histiocytosis.
A 23-year-old man presented with...
12/22/2015
The Dermatologist
12/16/2015
FEATURES
JANUARY – VOLUME 23, ISSUE 1
Business Insider Series: Leveraging Aesthetic Devices in Your Practice
No. 1, p. 22
Exploring Aesthetic Interventions: Fat Transfer for Mid-Face Lipoatrophy
No. 1, p. 30
Clinical Insights on...
FEATURES
JANUARY – VOLUME 23, ISSUE 1
Business Insider Series: Leveraging Aesthetic Devices in Your Practice
No. 1, p. 22
Exploring Aesthetic Interventions: Fat Transfer for Mid-Face Lipoatrophy
No. 1, p. 30
Clinical Insights on...
FEATURES
JANUARY – VOLUME 23,...
12/16/2015
The Dermatologist
